MedTrace Logo

The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure

NCT06580275 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-02-25

No results posted yet for this study

Summary

The CLAAS® device will be evaluated for safety and performance in the reduction of stroke in subjects with non-valvular atrial fibrillation under intracardiac echocardiography (ICE) imaging for left atrial appendage closure.

Conditions

Interventions

DEVICE

CLAAS

All eligible subjects will have an LAA closure attempt using the CLAAS device guided by ICE technology.

Sponsors & Collaborators

  • Conformal Medical, Inc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-24
Primary Completion
2025-11-10
Completion
2026-09-22
FDA Device
Yes

Countries

  • Czechia
  • Denmark
  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06580275 on ClinicalTrials.gov